Send us a text Preimplantation Genetic Testing for Aneuploidy, or PGT-A, a procedure used in IVF to screen embryos for chromosomal abnormalities before implantation, is increasingly facing scrutiny and criticism in 2025 due to mounting evidence of its limited effectiveness and potential drawbacks. Despite its widespread adoption in over half of U.S. IVF cycles, recent studies and expert opinions highlight that PGT-A has not consistently proven to improve pregnancy or live birth rates, with so...
All content for The Holistic Fertility Show is the property of Mike Berkley and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text Preimplantation Genetic Testing for Aneuploidy, or PGT-A, a procedure used in IVF to screen embryos for chromosomal abnormalities before implantation, is increasingly facing scrutiny and criticism in 2025 due to mounting evidence of its limited effectiveness and potential drawbacks. Despite its widespread adoption in over half of U.S. IVF cycles, recent studies and expert opinions highlight that PGT-A has not consistently proven to improve pregnancy or live birth rates, with so...
Can Acupuncture & Herbal Medicine Help You Conceive Even with a History of Endometriosis?
The Holistic Fertility Show
13 minutes
1 month ago
Can Acupuncture & Herbal Medicine Help You Conceive Even with a History of Endometriosis?
Send us a text For women with a history of endometriosis who have experienced failed cycles with Lupron—a medication that suppresses estrogen to manage symptoms—or after laparoscopy to remove endometrial lesions, acupuncture and herbal medicine offer complementary approaches that may enhance fertility by addressing underlying imbalances. Acupuncture can help regulate hormonal levels, reduce pelvic inflammation and pain, improve blood flow to the reproductive organs, and thicken the endometria...
The Holistic Fertility Show
Send us a text Preimplantation Genetic Testing for Aneuploidy, or PGT-A, a procedure used in IVF to screen embryos for chromosomal abnormalities before implantation, is increasingly facing scrutiny and criticism in 2025 due to mounting evidence of its limited effectiveness and potential drawbacks. Despite its widespread adoption in over half of U.S. IVF cycles, recent studies and expert opinions highlight that PGT-A has not consistently proven to improve pregnancy or live birth rates, with so...
